1                                            A P450arom inhibitor, letrozole, reduced 17beta-estradiol

2        The CYP19 gene encodes for aromatase (P450arom), a key steroidogenic enzyme that catalyzes the

3 ly, E(t)C.1 expressed active p450 Aromatase (P450arom), which was confirmed by the aromatization of a

4 the expression of cytochrome P450 aromatase (P450arom).

5  a key event responsible for aberrantly high P450arom expression in breast tumors, we studied the mol

6            Because the in vivo activation of P450arom promoter II is a key event responsible for aber

7 d the molecular basis for the enhancement of P450arom promoter II using human adipose fibroblasts (HA

8 ith DHA increased not only the expression of P450arom, but also 17beta-estradiol in the cerebral cort

9  TCM, HAFs displayed a striking induction of P450arom mRNA levels via promoter II usage.

10 ary testes demonstrated much lower levels of P450arom than in pig testis.

11                Expression of aromatase P450 (P450arom), which catalyzes the formation of estrogens, i

12                   Aromatase cytochrome P450 (P450arom), the enzyme that catalyzes estrogen synthesis,

13 s is catalyzed by aromatase cytochrome P450 (P450arom), the product of the cyp19 gene.

14                   Collared peccary placental P450arom expression also seemed much lower than pigs.

15         In tumor-free breast adipose tissue, P450arom is usually expressed at low levels via a distal

16 n the breast adipose tissue bearing a tumor, P450arom is increased through the activation of two prox

17 l of several distinct and alternatively used P450arom promoters.